Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2025-12-24 @ 9:54 PM
NCT ID:
NCT05716932
Eligibility Criteria:
Inclusion Criteria:
* We will enroll cases of RAM that had been treated by Direct and perilesional focal laser, followed by a single intravitreal ranibizumab injection a few days later, and had been followed up for at least 6 months
Exclusion Criteria:
* • RAM treated by a single approach (laser or intravitreal injections),
* RAM treated by other anti-VEGF injections (not ranibizumab),
* RAM with a shorter than 6 months of follow-up after combined laser and ranibizumab
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05716932
Study Brief:
Protocol Section:
NCT05716932